Estimated portfolio Estimated
This is a model, not an account statement.
Members disclose a dollar range per trade, never share counts or balances. Every share, value, weight and return below is derived: shares = range midpoint ÷ closing price on the trade date; positions are floored at zero; cash and dividends are not modelled. Compare against SPY using identical cash flows. As of Nov 5, 2026.
Est. portfolio value
Estimated$540,748
25 positions
Invested (cum.)
Estimated$1,793,608
Sum of buy midpoints
Realized (cum.)
Estimated$1,581,507
Modelled sell proceeds
Return vs SPY
Estimated+18.3%
SPY with identical cash flows: +11.2%
Return index Estimated
100 = each disclosed dollar is worth a dollar (value + realized) ÷ invested
- Portfolio (estimated)
- SPY with identical cash flows
Portfolio values, holdings, returns, and allocations are estimates derived from disclosed dollar ranges and public market prices. They may differ materially from actual values. Not investment advice. How this is calculated
Holdings Estimated
25 positions · sorted by est. value
| Sector | Buys / sells | Latest close | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GSThe Goldman Sachs Group, Inc. | 88.9 | $77,216 | 14.3% | $27,033 | $50,183(+185.6%) | Feb 28, 2022 | Financial Services | 8 / 6 | $868.95Nov 5, 2026 |
| MSMorgan Stanley | 383.0 | $69,873 | 12.9% | $32,501 | $37,372(+115.0%) | May 13, 2021 | Financial Services | 1 / 0 | $182.44Nov 5, 2026 |
| JPMJPMorgan Chase & Co. | 169.5 | $57,166 | 10.6% | $24,009 | $33,158(+138.1%) | Feb 28, 2022 | Financial Services | 4 / 1 | $337.34Nov 5, 2026 |
| CDNSCadence Design Systems, Inc. | 163.5 | $50,910 | 9.4% | $24,185 | $26,724(+110.5%) | Feb 28, 2022 | Technology | 4 / 1 | $311.43Nov 5, 2026 |
| KAIKadant Inc. | 160.6 | $48,102 | 8.9% | $25,553 | $22,549(+88.2%) | Feb 28, 2022 | Industrials | 4 / 1 | $299.45Nov 5, 2026 |
| COSTCostco Wholesale Corporation | 41.6 | $44,332 | 8.2% | $16,086 | $28,246(+175.6%) | Feb 28, 2022 | Consumer Defensive | 7 / 3 | $1,065.59Nov 5, 2026 |
| IAUiShares Gold Trust | 387.7 | $29,854 | 5.5% | $12,194 | $17,660(+144.8%) | Feb 28, 2022 | ETF | 3 / 5 | $77.00Nov 5, 2026 |
| REGNRegeneron Pharmaceuticals, Inc. | 28.0 | $25,251 | 4.7% | $16,410 | $8,841(+53.9%) | Feb 28, 2022 | Healthcare | 4 / 3 | $902.90Nov 5, 2026 |
| BRK-BBerkshire Hathaway Inc. | 41.6 | $23,802 | 4.4% | $12,600 | $11,201(+88.9%) | Feb 28, 2022 | Financial Services | 7 / 5 | $572.33Nov 5, 2026 |
| GOOGLAlphabet Inc. | 79.0 | $22,320 | 4.1% | $5,809 | $16,511(+284.2%) | May 1, 2020 | Communication Services | 3 / 2 | $282.57Nov 5, 2026 |
| FANUFFanuc Corporation | 614.6 | $20,643 | 3.8% | $28,805 | -$8,162(-28.3%) | Mar 1, 2022 | Industrials | 8 / 5 | $33.59Nov 5, 2026 |
| TJXThe TJX Companies, Inc. | 104.7 | $14,507 | 2.7% | $7,421 | $7,087(+95.5%) | Feb 28, 2022 | Consumer Cyclical | 5 / 7 | $138.59Nov 5, 2026 |
| RHHBYRoche Holding AG | 179.2 | $10,655 | 2.0% | $8,001 | $2,654(+33.2%) | Apr 22, 2020 | Healthcare | 1 / 0 | $59.45Nov 5, 2026 |
| IXJiShares Global Healthcare ETF | 89.8 | $10,139 | 1.9% | $8,001 | $2,138(+26.7%) | Dec 22, 2021 | ETF | 1 / 0 | $112.89Nov 5, 2026 |
| IYZiShares U.S. Telecommunications ETF | 246.1 | $8,948 | 1.7% | $8,001 | $947(+11.8%) | Dec 22, 2021 | ETF | 1 / 0 | $36.36Nov 5, 2026 |
| CVSCVS Health Corporation | 78.1 | $6,355 | 1.2% | $8,050 | -$1,694(-21.1%) | Feb 28, 2022 | Healthcare | 2 / 1 | $81.33Nov 5, 2026 |
| DISThe Walt Disney Company | 53.8 | $6,303 | 1.2% | $7,991 | -$1,689(-21.1%) | Feb 28, 2022 | Communication Services | 5 / 4 | $117.22Nov 5, 2026 |
| PEPPepsiCo, Inc. | 43.2 | $6,162 | 1.1% | $7,507 | -$1,345(-17.9%) | Feb 28, 2022 | Consumer Defensive | 4 / 6 | $142.71Nov 5, 2026 |
| AAGIYAIA Group Limited | 114.1 | $4,551 | 0.8% | $6,000 | -$1,449(-24.1%) | Dec 6, 2021 | Financial Services | 2 / 1 | $39.89Nov 5, 2026 |
| NTLAIntellia Therapeutics, Inc. | 142.2 | $1,579 | 0.3% | $3,298 | -$1,719(-52.1%) | Feb 28, 2022 | Healthcare | 3 / 6 | $11.10Nov 5, 2026 |
| RHHBFRoche Holding AG | 1.3 | $637 | 0.1% | $430 | $208(+48.4%) | Apr 14, 2021 | Healthcare | 1 / 2 | $491.50Nov 5, 2026 |
| CGNXCognex Corporation | 10.9 | $518 | 0.1% | $795 | -$277(-34.9%) | Feb 28, 2022 | Technology | 4 / 6 | $47.50Nov 5, 2026 |
| NVSNovartis AG | 2.5 | $404 | 0.1% | $212 | $191(+90.2%) | Feb 28, 2022 | Healthcare | 5 / 7 | $161.93Nov 5, 2026 |
| VZVerizon Communications Inc. | 7.2 | $333 | 0.1% | $370 | -$37(-9.9%) | Feb 28, 2022 | Communication Services | 3 / 8 | $46.12Nov 5, 2026 |
| SLBSLB N.V. | 3.8 | $190 | 0.0% | $110 | $80(+72.8%) | Mar 15, 2021 | Energy | 1 / 1 | $49.64Nov 5, 2026 |
Unrealized = est. value − est. cost basis (cost basis reduced pro-rata on modelled sells). Latest close from the price provider; may lag.
Sector allocation Estimated
- Financial Services43.0%$232.6K
- Industrials12.7%$68.7K
- Technology9.5%$51.4K
- Consumer Defensive9.3%$50.5K
- ETF9.1%$48.9K
- Healthcare8.3%$44.9K
- Communication Services5.4%$29K
- Consumer Cyclical2.7%$14.5K
- Energy0.0%$190
Excluded from the model
- 835 disclosed rows in total; 483 rows modelled.
- 314 rows had no published ticker (match confidence below the publish threshold).
- 0 rows were not a stock or ETF (options, bonds, funds, crypto, other).
- 30 rows had no closing price within the lookup window of the trade date.
- 8 rows were an exchange or an unknown transaction type.
- 50 sells had no modelled shares to sell ($1.5M of proceeds not modelled; positions are floored at zero).
Excluded rows still appear in the trade list with their official values; only the portfolio model skips them.
How this is calculatedmodel parameters · click to expand
- Shares formula
- amount_mid / close(tx_date)
- Return index
- 100 * (value + realized) / invested
- Benchmark
- SPY
- Portfolio start date
- 2020-01-01
- Price provider
- yfinance
- Price lookup window (days)
- 5
- Ticker publish threshold
- 0.9
- Positions floored at zero
- Yes
- Cash modelled
- No
- Dividends modelled
- No
Full method, tiers of ticker matching, and the review queue are documented on the methodology page.
Independent third-party platform; not affiliated with or endorsed by any member of Congress. Data sourced from publicly available filings and records. Portfolio, holdings, returns, and allocations are estimates and may differ from actual values. Informational and educational only; not investment advice.